spacer
home > ebr > summer 2003 > stimulating the growth of european biotechnology
PUBLICATIONS
European Biopharmaceutical Review

Stimulating the Growth of European Biotechnology

CORDIA - EuropaBio Convention 2003 - Europe's first comprehensive life science convention, providing a world-class stage for the European life science industry to come together. This unique event has been developed through an industry partnership between EuropaBio representing Europe's largest life science companies and National Biotechnology Associations, Consultants from Technomark, the specialist European life science consultancy and investor, and Reed Exhibitions Ltd, the world's largest event organiser.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sphere Fluidics receives Queen’s Award for Enterprise

Cambridge, UK, 21 April 2020: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, has be honored with a Queen’s Award for Enterprise for Innovation. The award recognizes the Company’s excellence in patenting, developing and globally commercializing single cell analysis systems for biotherapeutic discovery.
More info >>

White Papers

The Role of the CRO in Effective Risk-Based Monitoring

Medpace

The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging trial sponsors to transition from a focused on-site monitoring approach they have traditionally employed toward a risk-based approach that utilizes a combination of centralized and on-site monitoring techniques to ensure patient safety and data quality. The Risk-Based Monitoring (RBM) paradigm has many potential advantages over established monitoring practices including enhanced patient safety and data integrity, more efficient and effective protocol design, reduced costs, and the ability to strategically adjust oversight in keeping with changes in risk level.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement